mifepristone has been researched along with Parkinson Disease in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bähr, M; Cheng, S; Déglon, N; Konstantinova, P; Kügler, S; Liefhebber, J; Mazur, A; Pythoud, C; Raina, A; Rey, M; Streit, F; Tereshchenko, J; Vachey, G; Zimmer, V | 1 |
| Bähr, M; Kügler, S; Maddalena, A; Tereshchenko, J | 1 |
| Le, W; Li, T; Song, L; Wang, Y; Yang, D; Yang, J; Zhang, X | 1 |
| Hartwig, W | 1 |
1 review(s) available for mifepristone and Parkinson Disease
| Article | Year |
|---|---|
[Progress in endocrinology].
Topics: Abortion, Induced; Adrenal Medulla; Adult; Atrial Natriuretic Factor; Caudate Nucleus; Diuresis; Female; Humans; Mifepristone; Parkinson Disease; Pregnancy; Transplantation, Heterotopic | 1988 |
3 other study(ies) available for mifepristone and Parkinson Disease
| Article | Year |
|---|---|
Therapeutic efficacy of regulable GDNF expression for Huntington's and Parkinson's disease by a high-induction, background-free "GeneSwitch" vector.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adrenergic Agents; Animals; Disease Models, Animal; Gene Expression Regulation; Glial Cell Line-Derived Neurotrophic Factor; Green Fluorescent Proteins; Homovanillic Acid; Hormone Antagonists; Huntingtin Protein; Huntington Disease; Mice; Mice, Transgenic; Mifepristone; Oxidopamine; Parkinson Disease; Synapsins; Synucleins; Transduction, Genetic | 2018 |
Pharmacologically controlled, discontinuous GDNF gene therapy restores motor function in a rat model of Parkinson's disease.
Topics: Adenoviridae; Analysis of Variance; Animals; Disease Models, Animal; Dopamine; Functional Laterality; Genetic Therapy; Genetic Vectors; Glial Cell Line-Derived Neurotrophic Factor; Glial Fibrillary Acidic Protein; Hormone Antagonists; Mifepristone; Motor Activity; Oxidopamine; Parkinson Disease; Rats; Rotation; Sympatholytics; Time Factors; Vesicular Monoamine Transport Proteins | 2014 |
Mifepristone-inducible caspase-1 expression in mouse embryonic stem cells eliminates tumor formation but spares differentiated cells in vitro and in vivo.
Topics: Animals; Antineoplastic Agents; Caspase 1; Cell Death; Cell Survival; Dopaminergic Neurons; Embryonic Stem Cells; Enzyme Activation; Enzyme Activators; Female; Gene Expression Regulation; Genes, Reporter; Green Fluorescent Proteins; Male; Mice; Mice, Nude; Mifepristone; Neoplasms, Experimental; Parkinson Disease; Regenerative Medicine; Teratoma; Tumor Burden | 2012 |